| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |